Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Capital Expenditures: 2010-2024

Historic Capital Expenditures for ProPhase Labs (PRPH) over the last 13 years, with Dec 2024 value amounting to $40,000.

  • ProPhase Labs' Capital Expenditures fell 83.26% to $40,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year decrease of 45.06%. This contributed to the annual value of $906,000 for FY2024, which is 56.53% down from last year.
  • Latest data reveals that ProPhase Labs reported Capital Expenditures of $40,000 as of Q4 2024, which was up 4,100.00% from -$1,000 recorded in Q3 2024.
  • ProPhase Labs' 5-year Capital Expenditures high stood at $3.9 million for Q1 2021, and its period low was -$446,000 during Q2 2023.
  • Over the past 3 years, ProPhase Labs' median Capital Expenditures value was $668,000 (recorded in 2023), while the average stood at $628,091.
  • Per our database at Business Quant, ProPhase Labs' Capital Expenditures surged by 6,011.11% in 2022 and then tumbled by 166.17% in 2023.
  • Quarterly analysis of 5 years shows ProPhase Labs' Capital Expenditures stood at $1.5 million in 2020, then slumped by 101.84% to -$27,000 in 2021, then soared by 6,011.11% to $1.6 million in 2022, then plummeted by 85.03% to $239,000 in 2023, then tumbled by 83.26% to $40,000 in 2024.
  • Its last three reported values are $40,000 in Q4 2024, -$1,000 for Q3 2024, and $867,000 during Q1 2024.